/
HPV:  TRANSMISSION & DISINFECTION HPV:  TRANSMISSION & DISINFECTION

HPV: TRANSMISSION & DISINFECTION - PowerPoint Presentation

davis
davis . @davis
Follow
343 views
Uploaded On 2022-06-11

HPV: TRANSMISSION & DISINFECTION - PPT Presentation

Introduction to HPV OVERVIEW Recent advances in testing with HPV HPV amp related diseases Transmission Tristel amp HPV amp ME WHAT IS HPV Human papillomavirus Small nonenveloped DNA virus ID: 917190

amp hpv transmission tristel hpv amp tristel transmission high testing human dioxide cancer chlorine papillomavirus disinfection probes transvaginal medical

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "HPV: TRANSMISSION & DISINFECTION" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

HPV:

TRANSMISSION & DISINFECTION

Slide2

Introduction to HPV

OVERVIEW

Recent advances in testing with HPV

HPV & related diseases

Transmission

Tristel & HPV

Slide3

& ME

WHAT IS HPV?

Human papillomavirus

Small non-enveloped DNA virus

Physically stable and resistant with long durability

Most sexually transmitted disease worldwide

Over 200 different types identifiedHPV classified into high-risk and low-risk types

Slide4

HPV is associated with skin infections:

These result in non-cancerous skin growths (warts).Infections in genital area are associated with genital or anal warts.Mouth papillomas (benign epithelial tumours).

Chronic infections of the cervix with HPV 16 and 18 causes cervical intraepithelial neoplasia (CIN) and leads to cancer.

HPV is found in about 99% of cervical cancers.

More than 70% of these are caused by HPV types 16 and 18.

HPV is also responsible for other anogenital cancers and oropharyngeal (throat) cancers.

HPV type 16 is responsible for up to 60% of all HPV-associated cancers.& MEDISEASES & PREVALENCE

Slide5

& ME

Source: https://en.wikipedia.org/wiki/Human_papillomavirus_infection

NOTABLE HPV TYPES AND ASSOCIATED DISEASES

Slide6

& ME

(2002)

Source: Parkin, 2006

HPV & CANCER

Slide7

HPV is spread predominantly through sexual intercourse.

Other routes of transmission include:Vertical transmission:From parent to offspring.

From mother to embryo, foetus or baby during pregnancy or childbirth.

At fertilisation via infected oocyte or spermatozoon.

Horizontal transmission:

Via fomites.

Through kissing or hand-genital contact.Through medical procedures such as colposcopy and transvaginal ultrasonography or ENT procedures.This presentation focuses on HPV transmission which can occur in medical facilities (nosocomial).& ME

ROUTES OF TRANSMISSION

Slide8

Nosocomial transmission via:

Medical devices which enter cavities such as transvaginal or transrectal probes or laryngoscopes.Medical surfaces - HPV retains 30% of its infectivity even after dehydration for 7 days.Transvaginal probes are routinely protected by a condom, which acts as a physical barrier to contamination.

Studies have shown that 0.9% - 5% of the condoms get punctured during procedures.

It has been shown that low-level disinfection does not remove all HPV DNA from infected probes.

HPV DNA has also been found present on sterilised medical instruments used in patients with HPV genital tract infection.

& ME

RISKS OF TRANSMISSION

Slide9

& ME

DISINFECTION HAS NOT BEEN WORKING

2012 study found that

7.5%

of transvaginal sonography probes (TVS) were HPV + in A&E.

2011 study found of 198 samples, 7 (3.5%) were HPV + in gynaecology department after endovaginal ultrasound procedure.Same study also found that HPV was found in 6 out of 216 (2.8%) samples before procedure.Using a similar technique another 2012 study found 7.5% of the samples were HPV positive.2014 study found HPV negative mothers had infants with HPV.

HPV & TRISTEL PRODUCTS

Slide10

& ME

Study showed that HPV was identified on objects (fomites)

commonly used in

gynaecological

care.

Source:

Human papillomavirus (HPV) contamination of gynaecological equipment, Switzerland, 2015HPV & TRISTEL PRODUCTS

Slide11

& ME

11 commonly used disinfectants -only 0.525% hypochlorite (bleach)

and 1.2% PAA-silver worked!

Source:

Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants - Department of Microbiology and immunology, Pennsylvania State College of Medicine, USA

HPV & TRISTEL PRODUCTS

Slide12

& ME

WHY USE TRISTEL?

Commonly used clinical disinfectants, including those used as sterilants in medical and dental healthcare facilities have not been working.

This has been noticed by various health authorities and policy changes concerning disinfectant use has meant that the need for high-level disinfection has become more pronounced.

Tristel offers the level of disinfection needed to get the job done!

HPV & TRISTEL PRODUCTS

Slide13

& ME

TRISTEL PRODUCT QUALITIES

Chemistry is safe to patient, staff and environment

Unblemished Health and Safety record of over 20 years

Effective against a wide range of microorganisms due to oxidation properties

Microorganisms are unable to build resistance against chlorine dioxide

Decontamination process is fast by industry standards (within minutes)Excellent material compatibilityCompliance with local and international regulationSimple, portable and affordable HPV & TRISTEL PRODUCTS

Slide14

& ME

HPV & TRISTEL PRODUCTS

Other uses include high-level disinfection of non-invasive medical devices, such as:

Transabdominal probes

Bladder scanners

Blood pressure cuffs

Chemistry: Chlorine dioxide (ClO2)Intended use: high-level disinfection of

endocavity ultrasound probes, such as:Transvaginal ultrasound probesTransrectal ultrasound probesTristel Duo ULT

Slide15

& ME

Tristel Trio Wipe System

Nasendoscopes

Transoesophageal echocardio probes (TOE/TEE)

Laryngoscope blades

Intubation endoscopes

Manometry cathetersEndocavity ultrasound probesLaryngoscopesOphthalmic instrumentsChemistry: Chlorine dioxide (ClO2)Intended use: high-level disinfection of non-lumened invasive and non-invasive medical devices, such as: 

HPV & TRISTEL PRODUCTS

Slide16

Chlorine dioxide (ClO2) is a powerful oxidant and eliminates microorganisms through oxidation.

Oxidants are substances which remove electrons from other atoms.Chlorine dioxide ‘steals’ electrons from microorganisms disrupting the cells. This leads to cell death. Chlorine dioxide inactivates viruses by inducing oxidative stress.ClO2 inactivates Poliovirus by reacting with the viral RNA and impairing RNA synthesis.

ClO2 inactivates Influenza virus

through specific oxidative modifications of specific amino acids residues on specific proteins.

Tristel chemistry: Chlorine dioxide

Slide17

& ME

THE IMPORTANCE OF REMAINING CURRENT

To maintain and potentially expand it’s share of the market Tristel must keep pace.

It is better to survey, anticipate and prepare for changes than tackle them as they arrive.

Changes are anticipated for HPV…

This includes testing new diseases or updating products with changes in regulatory testing method/standard.

ADVANCES IN HPV TESTING

Slide18

& ME

LATEST DEVELOPMENTS

The ability of HPV to infect host can now be measured.

Two systems have been developed capable of producing high quantities of HPV virus.

ADVANCES IN HPV TESTING

Slide19

& ME

Testing has been performed with Duo ULT and Trio Wipes System against native HPV 16 and 18.

This testing has demonstrated that both of these disinfectants are effective.

Duo ULT and Trio Wipes System are based on chlorine dioxide chemistry which inactivate viruses by reacting with the viral RNA and impairing RNA synthesis.

We are moving forward to also include simulated use testing on devices to simulate real-life testing.

ADVANCES IN HPV TESTING

Slide20

Alvarez and O’Brien (1982)

Mechanisms of inactivation of poliovirus by chlorine dioxide and iodine. Appl Environ Microbiol, 44(5):1064-71.

Casalegno

et al. (2012)

High risk HPV contamination of

endocavity

vaginal ultrasound probes: an underestimated route of nosocomioal infection? PLoS One, 7(10): e48137.Ferenczy et al. (1989) HPV DNA in Fomites on Objects Used for the Management of Patients With Genital HPV Infections. Obstet Gynecol. 74(6): 950-4.Gallay et al. (2016) Human papillomavirus (HPV) contamination of gynaecological equipment. Sex Transm Infect.

92: 19-23. Khan et al., (2005) High level disinfeThe elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 97(14): 1072-9.Ma et al. (2012) Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. Emerg Med J. 30(6): 472-5. Ma et al. (2012) High level disinfection reduces HPV contamination of transvaginal sonography probes in the emergency department. Published as a response to “ Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. (Ma et al., 2012)”

Meyers et al. (2014) Susceptibility of high-risk HPV type 16 to clinical disinfectants. J Antimicrob Chemother. 69(6): 1546-50.Miura and Shibata (2010) Antiviral Effect of Chlorine Dioxide against Influenza Virus and Its Application for Infection Control. The Open Antimicrobial Agents Journal. 2: 71-8. National Cervical Cancer Coalition. Cervical Cancer Overview . Available at: http://www.nccc-online.org/hpvcervical-cancer/cervical-cancer-overview/. Accessed: 05/04/2018.

Tota et al. (2011) Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 53 Suppl 1: S12-21.Parkin (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 118(12): 3030-44.Ryndock and Meyers (2014) A risk for non-sexual transmission of human papillomavirus? Expert Rev Anti Infect Ther.

12(10): 1165-70.

Sabeena et al. (2017) Possible non-sexual modes of transmission of human papilloma virus.

J Obstet Gynaecol

Res. 43(3): 429-35.

Syrjanen (2005) Human papillomavirus (HPV) in head and neck cancer

. J Clin Virol

. 32 Suppl 1: S59-66.

REFERENCES

Slide21